Structural characterization of p53 isoforms due to the polymorphism at codon 72 by mass spectrometry and circular dichroism

Marina Naldi, Marco Pistolozzi, Carlo Bertucci, Angela De Simone, Serena Altilia, Michela Pierini, Claudio Franceschi, Stefano Salvioli, Vincenza Andrisano

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

A common polymorphism at codon 72 of human TP53 gene determines a proline to arginine aminoacidic substitution within the proline-rich domain of p53 protein. The two resulting isoforms (p53P72 and p53R72) are different from a biochemical and biological point of view and many reports suggest that they can modulate individual cancer susceptibility and overall survival. In the attempt to explain the observed biological differences, we characterized the two isoforms by mass spectrometry and circular dichroism (CD) to evaluate the possible alteration in the secondary structure of p53 introduced by this polymorphism.Recombinant human p53R72 and p53P72 were produced by using E. coli expression system then purified by chromatography (affinity chromatography and RP-HPLC), and the whole proteins identified by HPLC-ESI-IT and MALDI-TOF analysis. A bottom-up approach, using both MALDI-TOF and HPLC-ESI-QTOF analysis, was then adopted to obtain the sequence information on the two p53 isoforms. To this purpose, peptide maps were obtained by trypsin proteolysis on the two p53 isoforms. The two isoforms proteolytic digests were separated by LC and subsequent mass spectrometry analysis of both entire and fragmented peptides was performed. In particular, precursor peptide ions obtained by ESI were subjected to collision by the triple quadrupole and TOF separation, allowing us to determine the isoforms aminoacidic peptide sequence by peptide ladder sequencing. Because of the presence of arginine, a selective trypsin proteolytic cleavage at R72, giving rise to two selective shorter peptides, occurred in p53R72, but was missing in the case of p53P72 trypsin digest, in which an uncleaved longer peptide was instead identified. Upon primary structure confirmation, the two p53 isoforms were studied by CD in order to investigate the experimental variables, which affect ordered secondary structure adoption. CD analysis indicated that the two isoforms are not structurally different, thus allowing us to exclude that the observed biological differences can be due to a different conformation of the two isoforms introduced by this polymorphism. Furthermore, these studies establish a mass spectrometry method to identify the two isoforms that can be useful for future interactome studies and cancer drug discovery.

Original languageEnglish
Pages (from-to)200-206
Number of pages7
JournalJournal of Pharmaceutical and Biomedical Analysis
Volume53
Issue number2
DOIs
Publication statusPublished - 2010

Fingerprint

Circular Dichroism
Polymorphism
Codon
Mass spectrometry
Mass Spectrometry
Protein Isoforms
Peptides
Trypsin
Matrix-Assisted Laser Desorption-Ionization Mass Spectrometry
High Pressure Liquid Chromatography
Proline-Rich Protein Domains
Proline
Arginine
Proteolysis
Affinity chromatography
p53 Genes
Ladders
Drug Discovery
Affinity Chromatography
Escherichia coli

Keywords

  • Circular dichroism
  • LC-ESI-IT
  • LC-ESI-QTOF
  • MALDI-TOF
  • P53 Isoforms p53P<sup>72</sup> and p53R<sup>72</sup>
  • Primary and secondary structure characterizations
  • Tryptic digest

ASJC Scopus subject areas

  • Analytical Chemistry
  • Drug Discovery
  • Pharmaceutical Science
  • Spectroscopy
  • Clinical Biochemistry
  • Medicine(all)

Cite this

Structural characterization of p53 isoforms due to the polymorphism at codon 72 by mass spectrometry and circular dichroism. / Naldi, Marina; Pistolozzi, Marco; Bertucci, Carlo; De Simone, Angela; Altilia, Serena; Pierini, Michela; Franceschi, Claudio; Salvioli, Stefano; Andrisano, Vincenza.

In: Journal of Pharmaceutical and Biomedical Analysis, Vol. 53, No. 2, 2010, p. 200-206.

Research output: Contribution to journalArticle

Naldi, Marina ; Pistolozzi, Marco ; Bertucci, Carlo ; De Simone, Angela ; Altilia, Serena ; Pierini, Michela ; Franceschi, Claudio ; Salvioli, Stefano ; Andrisano, Vincenza. / Structural characterization of p53 isoforms due to the polymorphism at codon 72 by mass spectrometry and circular dichroism. In: Journal of Pharmaceutical and Biomedical Analysis. 2010 ; Vol. 53, No. 2. pp. 200-206.
@article{0f449bab0dc545a4b3f8bafb7d2f0c66,
title = "Structural characterization of p53 isoforms due to the polymorphism at codon 72 by mass spectrometry and circular dichroism",
abstract = "A common polymorphism at codon 72 of human TP53 gene determines a proline to arginine aminoacidic substitution within the proline-rich domain of p53 protein. The two resulting isoforms (p53P72 and p53R72) are different from a biochemical and biological point of view and many reports suggest that they can modulate individual cancer susceptibility and overall survival. In the attempt to explain the observed biological differences, we characterized the two isoforms by mass spectrometry and circular dichroism (CD) to evaluate the possible alteration in the secondary structure of p53 introduced by this polymorphism.Recombinant human p53R72 and p53P72 were produced by using E. coli expression system then purified by chromatography (affinity chromatography and RP-HPLC), and the whole proteins identified by HPLC-ESI-IT and MALDI-TOF analysis. A bottom-up approach, using both MALDI-TOF and HPLC-ESI-QTOF analysis, was then adopted to obtain the sequence information on the two p53 isoforms. To this purpose, peptide maps were obtained by trypsin proteolysis on the two p53 isoforms. The two isoforms proteolytic digests were separated by LC and subsequent mass spectrometry analysis of both entire and fragmented peptides was performed. In particular, precursor peptide ions obtained by ESI were subjected to collision by the triple quadrupole and TOF separation, allowing us to determine the isoforms aminoacidic peptide sequence by peptide ladder sequencing. Because of the presence of arginine, a selective trypsin proteolytic cleavage at R72, giving rise to two selective shorter peptides, occurred in p53R72, but was missing in the case of p53P72 trypsin digest, in which an uncleaved longer peptide was instead identified. Upon primary structure confirmation, the two p53 isoforms were studied by CD in order to investigate the experimental variables, which affect ordered secondary structure adoption. CD analysis indicated that the two isoforms are not structurally different, thus allowing us to exclude that the observed biological differences can be due to a different conformation of the two isoforms introduced by this polymorphism. Furthermore, these studies establish a mass spectrometry method to identify the two isoforms that can be useful for future interactome studies and cancer drug discovery.",
keywords = "Circular dichroism, LC-ESI-IT, LC-ESI-QTOF, MALDI-TOF, P53 Isoforms p53P<sup>72</sup> and p53R<sup>72</sup>, Primary and secondary structure characterizations, Tryptic digest",
author = "Marina Naldi and Marco Pistolozzi and Carlo Bertucci and {De Simone}, Angela and Serena Altilia and Michela Pierini and Claudio Franceschi and Stefano Salvioli and Vincenza Andrisano",
year = "2010",
doi = "10.1016/j.jpba.2010.03.038",
language = "English",
volume = "53",
pages = "200--206",
journal = "Journal of Pharmaceutical and Biomedical Analysis",
issn = "0731-7085",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Structural characterization of p53 isoforms due to the polymorphism at codon 72 by mass spectrometry and circular dichroism

AU - Naldi, Marina

AU - Pistolozzi, Marco

AU - Bertucci, Carlo

AU - De Simone, Angela

AU - Altilia, Serena

AU - Pierini, Michela

AU - Franceschi, Claudio

AU - Salvioli, Stefano

AU - Andrisano, Vincenza

PY - 2010

Y1 - 2010

N2 - A common polymorphism at codon 72 of human TP53 gene determines a proline to arginine aminoacidic substitution within the proline-rich domain of p53 protein. The two resulting isoforms (p53P72 and p53R72) are different from a biochemical and biological point of view and many reports suggest that they can modulate individual cancer susceptibility and overall survival. In the attempt to explain the observed biological differences, we characterized the two isoforms by mass spectrometry and circular dichroism (CD) to evaluate the possible alteration in the secondary structure of p53 introduced by this polymorphism.Recombinant human p53R72 and p53P72 were produced by using E. coli expression system then purified by chromatography (affinity chromatography and RP-HPLC), and the whole proteins identified by HPLC-ESI-IT and MALDI-TOF analysis. A bottom-up approach, using both MALDI-TOF and HPLC-ESI-QTOF analysis, was then adopted to obtain the sequence information on the two p53 isoforms. To this purpose, peptide maps were obtained by trypsin proteolysis on the two p53 isoforms. The two isoforms proteolytic digests were separated by LC and subsequent mass spectrometry analysis of both entire and fragmented peptides was performed. In particular, precursor peptide ions obtained by ESI were subjected to collision by the triple quadrupole and TOF separation, allowing us to determine the isoforms aminoacidic peptide sequence by peptide ladder sequencing. Because of the presence of arginine, a selective trypsin proteolytic cleavage at R72, giving rise to two selective shorter peptides, occurred in p53R72, but was missing in the case of p53P72 trypsin digest, in which an uncleaved longer peptide was instead identified. Upon primary structure confirmation, the two p53 isoforms were studied by CD in order to investigate the experimental variables, which affect ordered secondary structure adoption. CD analysis indicated that the two isoforms are not structurally different, thus allowing us to exclude that the observed biological differences can be due to a different conformation of the two isoforms introduced by this polymorphism. Furthermore, these studies establish a mass spectrometry method to identify the two isoforms that can be useful for future interactome studies and cancer drug discovery.

AB - A common polymorphism at codon 72 of human TP53 gene determines a proline to arginine aminoacidic substitution within the proline-rich domain of p53 protein. The two resulting isoforms (p53P72 and p53R72) are different from a biochemical and biological point of view and many reports suggest that they can modulate individual cancer susceptibility and overall survival. In the attempt to explain the observed biological differences, we characterized the two isoforms by mass spectrometry and circular dichroism (CD) to evaluate the possible alteration in the secondary structure of p53 introduced by this polymorphism.Recombinant human p53R72 and p53P72 were produced by using E. coli expression system then purified by chromatography (affinity chromatography and RP-HPLC), and the whole proteins identified by HPLC-ESI-IT and MALDI-TOF analysis. A bottom-up approach, using both MALDI-TOF and HPLC-ESI-QTOF analysis, was then adopted to obtain the sequence information on the two p53 isoforms. To this purpose, peptide maps were obtained by trypsin proteolysis on the two p53 isoforms. The two isoforms proteolytic digests were separated by LC and subsequent mass spectrometry analysis of both entire and fragmented peptides was performed. In particular, precursor peptide ions obtained by ESI were subjected to collision by the triple quadrupole and TOF separation, allowing us to determine the isoforms aminoacidic peptide sequence by peptide ladder sequencing. Because of the presence of arginine, a selective trypsin proteolytic cleavage at R72, giving rise to two selective shorter peptides, occurred in p53R72, but was missing in the case of p53P72 trypsin digest, in which an uncleaved longer peptide was instead identified. Upon primary structure confirmation, the two p53 isoforms were studied by CD in order to investigate the experimental variables, which affect ordered secondary structure adoption. CD analysis indicated that the two isoforms are not structurally different, thus allowing us to exclude that the observed biological differences can be due to a different conformation of the two isoforms introduced by this polymorphism. Furthermore, these studies establish a mass spectrometry method to identify the two isoforms that can be useful for future interactome studies and cancer drug discovery.

KW - Circular dichroism

KW - LC-ESI-IT

KW - LC-ESI-QTOF

KW - MALDI-TOF

KW - P53 Isoforms p53P<sup>72</sup> and p53R<sup>72</sup>

KW - Primary and secondary structure characterizations

KW - Tryptic digest

UR - http://www.scopus.com/inward/record.url?scp=77953497709&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953497709&partnerID=8YFLogxK

U2 - 10.1016/j.jpba.2010.03.038

DO - 10.1016/j.jpba.2010.03.038

M3 - Article

C2 - 20427142

AN - SCOPUS:77953497709

VL - 53

SP - 200

EP - 206

JO - Journal of Pharmaceutical and Biomedical Analysis

JF - Journal of Pharmaceutical and Biomedical Analysis

SN - 0731-7085

IS - 2

ER -